The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries
Open accessAbstract
The final text of the Trans Pacific Partnership Agreement (TPP), agreed between the 12 negotiating countries in 2016, included a suite of intellectual property provisions intended to expand and extend pharmaceutical company exclusivities on medicines. It drew wide criticism for including such provisions in an agreement that involved developing countries (Vietnam, Peru, Malaysia, Mexico, Chile and Brunei Darussalam) because of the effect on delaying the introduction of low-cost generics. While developing nations negotiated transition periods for implementing some obligations, all parties would have eventually been expected to meet the same standards had the TPP come into force. While the TPP has stalled following US withdrawal, there are moves by some of the remaining countries to reinvigorate the agreement without the United States. The proponents may seek to retain as much as possible of the original text in the hope that the United States will re-join the accord in future. This article presents a comparative analysis of the impact the final 2016 TPP intellectual property chapter could be expected to have (if implemented in its current form) on the intellectual property laws and regulatory regimes for medicines in the TPP countries. Drawing on the published literature, it traces the likely impact on access to medicines. It focuses particularly on the differential impact on regulatory frameworks for developed and developing nations (in terms of whether or not legislative action would have been required to implement the agreement). The article also explores the political and economic dynamics that contributed to these differential outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, trade agreements and policies directly influence social determinants of health, affecting access to essential medicines, availability of nutritious foods, and safety of environments through economic development and regulatory frameworks (2–6).”
From Global Health Trade Summit: an AI-enhanced simulation of international trade and global health for undergraduate public health education (2025) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLOBAL ECONOMIC PROSPECTS: THE RECESSION MAY BE OVER BUT WHERE NEXT?
(2013) · The Financial Crisis and the Global South · doi:10.2307/j.ctt183pb3w.5 · Cited by 908
Gruber, H. (2001) · Information Economics and Policy · doi:10.1016/s0167-6245(00)00028-7 · Cited by 411
Office of the United States Trade Representative
(2013) · Choice Reviews Online · doi:10.5860/choice.51-0991 · Cited by 346
Behind the scenes at the WTO: the real world of international trade negotiations
(2004) · Choice Reviews Online · doi:10.5860/choice.41-4154 · Cited by 255
The Economic Effects of the Trans-Pacific Partnership: New EstimatesPreprint
Petri, P. A., & Plummer, M. G. (2016) · SSRN Electronic Journal · doi:10.2139/ssrn.2723413 · Cited by 202
Developing Countries and International Intellectual Property Standard‐Setting
Drahos, P. (2002) · The Journal of World Intellectual Property · doi:10.1111/j.1747-1796.2002.tb00181.x · Cited by 188
Investments in Pharmaceuticals Before and After TRIPS
Kyle, M. K., & McGahan, A. M. (2012) · Review of Economics and Statistics · doi:10.1162/rest_a_00214 · Cited by 178
Trade, TRIPS, and pharmaceuticals
Smith, R. D., Correa, C., & Oh, C. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61779-1 · Cited by 173
Global value chains and development
Ravenhill, J. (2014) · Review of International Political Economy · doi:10.1080/09692290.2013.858366 · Cited by 152
Waning, B. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.058925 · Cited by 124
Research works printed but not linked: 7
- Kelsey J (2013) Press release: Heavy-handed tactics in TPPA talks aim to isolate dissenters. Available at: https://itsourfuture.org.nz/heavy-handed-tactics-in-tppa-talks-aim-to-isolate-dissenters/ (accessed 28 May 2017).
- Palmedo M, 2013, Currents International Trade Law Journal, 21, 38
- Park W, 2007, Frontiers of Economics and Globalisation. Amsterdam: Elsevier, 289
- Pharmaceutical Research and Manufacturers of America (2013) PhRMA Urges Trans-Pacific Partnership negotiators to adopt a strong intellectual property framework. Available at: http://www.phrma.org/press-release/phrma-urges-trans-pacific-partnership-negotiators-to-adopt-a-strong-intellectual-property-framework (accessed 21 May 2017).
- Scassa T, 2001, Health Law Journal, 9, 23
- Trans Pacific Partnership (2011) Intellectual property rights chapter draft, 10 February. Available at: http://keionline.org/sites/default/files/tpp-10feb2011-us-text-ipr-chapter.pdf (accessed 17 August 2013).
- Trans Pacific Partnership (2016) Trans Pacific Partnership Agreement chapter 18: Intellectual property. Available at: https://www.mfat.govt.nz/assets/_securedfiles/trans-pacific-partnership/text/18.intellectual-property-chapter.pdf (accessed 9 June 2017).
Cited by
BitCoin: A new basket for eggs?
Qin, M., Su, C., & Tao, R. (2020) · Economic Modelling · doi:10.1016/j.econmod.2020.02.031 · Cited by 122
SHOULD BITCOIN BE HELD UNDER THE U.S. PARTISAN CONFLICT?
Su, C., Qin, M., Zhang, X.-L., Tao, R., & Umar, M. (2021) · Technological and Economic Development of Economy · doi:10.3846/tede.2021.14058 · Cited by 56
Gleeson, D., Lexchin, J., Labonté, R., Townsend, B., Gagnon, M., Köhler, J. C., Forman, L., & Shadlen, K. C. (2019) · Globalization and Health · doi:10.1186/s12992-019-0518-2 · Cited by 51
Self-citationThe politics of climate: Does factionalism impede U.S. carbon neutrality?
Qin, M., Su, Y. H., Zhao, Z., & Mirza, N. (2023) · Economic Analysis and Policy · doi:10.1016/j.eap.2023.04.039 · Cited by 40
Son, K., Lopert, R., Gleeson, D., & Lee, T.-J. (2018) · Globalization and Health · doi:10.1186/s12992-018-0423-0 · Cited by 35
Self-citation
Metadata
- Authors
- Gleeson, D., Lexchin, J., Lopert, R., & Kilic, B.
- Affiliations
- La Trobe University (AU)
- York University (CA)
- George Washington University (US)
- Public Citizen (US)
- Corresponding author
- Gleeson, Deborah
- Venue
- Global Social Policy
- Publisher
- SAGE Publications
- Published
- 2017-10-13
- Volume
- 18
- Issue
- 1
- Pages
- 7-27
- ISSN
- 1468-0181 (ISSN-L)
- 1741-2803
- PMC
- PMC5892849
- OpenAlex
- W2765265353
- Cited by
- 41
- References
- 37
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 4 · 2021: 5 · 2020: 10 · 2019: 6 · 2018: 4
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Global Social Policy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc)
- La Trobe University
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Social Sciences › Law › Intellectual Property Law
- Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Intellectual Property and Patents
- Keywords
- Trans-Pacific Partnership, intellectual property, pharmaceutical patents, access to medicines, generic drugs, developing countries, developed countries, trade agreements, drug exclusivity, US withdrawal from TPP
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries. https://app.cochat.ai/papers/10.1177/1468018117734153
- The paper
- Gleeson, D., Lexchin, J., Lopert, R., & Kilic, B. (2018). The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries. Global Social Policy. https://doi.org/10.1177/1468018117734153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.